ZEB2 and hepatocellular carcinoma: MiR-211-5p has been linked to short survival in hepatocellular carcinoma patients, and the restoration of miR-211-5p expression inhibited hepatocellular carcinoma cell proliferation, migration and invasion in vitro by targeting ZEB2[19].